Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5872 posts found.

afrezza_insulin

Sanofi abandons MannKind’s failed inhalable insulin

January 6, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Afrezza, Mannkind, Sanofi, insulin

Sanofi is to exit a licensing and co-marketing deal with MannKind for the inhalable insulin Afrezza, after disappointing sales figures …
News
Actelion logo

Actelion’s Uptravi goes on sale

January 5, 2016 Manufacturing and Production, Sales and Marketing Actelion, PAH, Uptravi, pulmonary arterial hypertension, pulmonary hypertension, selexipag

Swiss pharma firm Actelion has put its new drug for pulmonary hypertension, Uptravi, up for sale in the US, weeks …
News
Baxalta logo

Bayer and Baxalta in separate €1 billion-plus deals

January 5, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Ascensia diabetes care, Baxalta, Bayer, diabetes, panasonic, symphogen

Baxalta has signed a deal with Symphogen potentially worth as much as €1.4 billion, under which the companies will develop …
News
Ovarian cancer

Pfizer, Merck and Syndax in ovarian cancer trial collaboration

January 5, 2016 Manufacturing and Production, Research and Development Merck, Pfizer, Syndax Pharmaceuticals, avelumab, entinostat, ovarian cancer

Pfizer, Merck and Syndax Pharmaceuticals have announced a collaboration to test avelumab, in combination with Syndax’s entinostat, in patients with …
News
erbitux-resized

Merck’s Erbitux approved for NHS Wales

January 5, 2016 Manufacturing and Production, Sales and Marketing Erbitux, Merck, cetuximab, colorectal cancer, metastatic colorectal cancer

The All Wales Medicines Strategy Group has recommended Merck’s Erbitux in combination with chemotherapy for restricted use in the NHS …
News
redx

Former Merck R&D expert joins RedX Pharma board

January 4, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RedX Pharma

Dr Bernhard Kirschbaum, 57, has been added as a non-executive director at RedX Pharma with immediate effect. Kirschbaum is a …
Appointment
pharma manufacturing

‘Rejuvenated’ pharma manufacturing set for 2016 comeback

January 4, 2016 Manufacturing and Production, Sales and Marketing Employment, industry, manufacturing, patent cliff, pharma, production

The pharma industry has been singled out for its strong performance in 2015, in a report which says manufacturing in …
News
Ebola virus

WHO to review MSD’s Ebola vaccine for emergency use

December 24, 2015 Manufacturing and Production, Research and Development Ebola vaccine, Ebola virus, MSD, WHO, Zebov

The World Health Organisation (WHO) has accepted MSD’s application for the company’s investigational Ebola vaccine, V920 (Zebov), to be reviewed …
News
Dr Andreas Barner

Boehringer Ingelheim invests in Europe

December 24, 2015 Manufacturing and Production, Sales and Marketing Austria, Biberach, Boehringer Ingelheim, Vienna, biologicals, manufacturing, production

Boehringer Ingelheim will kick off its pharma investments in 2016 with a half a billion Euro outlay and plans to …
News
Pills image

OTC drugs market boosted by growing patient demand

December 24, 2015 Manufacturing and Production, Sales and Marketing GBI Research, OTC, generics, over the counter

Increasing pressures from customers, drug manufacturers and regulators to convert prescription medications to over-the-counter (OTC) non-prescription status is driving growth …
News
2016

Seven pharma trends for 2016

December 24, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

What will be the key industry trends in 2016?Pricing pressures
Feature
Celgene logo

Celgene settles Revlimid patent dispute

December 23, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Celgene, India, Natco, Revlimid, lenalidomide, patents

Celgene has settled its litigation with Natco Pharma, over the patents for Revlimid, opening the door to increased generic competition …
News
Gilenya

EMA adds warning label to Novartis’ MS treatment Gilenya

December 22, 2015 Manufacturing and Production EMA, European Medicines Agency, FDA, Novartis, PML, basal cell carcinoma, fingolimod, gilenya

Drug safety regulators in Europe have said they will add warnings to the label and prescribing information of Gilenya (fingolimod), …
News
ABPI

Pharma industry will pay £550m of NHS 2016 drugs bill

December 22, 2015 Manufacturing and Production ABPI, PPRS, Pharmaceutical Price Regulation Scheme

A new financial agreement announced this week as part of the Pharmaceutical Price Regulation Scheme (PPRS), will see the pharmaceutical …
News
Sun Pharma logo

Sun Pharma hit by FDA inspection warning

December 22, 2015 Manufacturing and Production FDA, Sun Pharma, manufacturing, production

Sun Pharma shares fell some 7% early this week after it emerged the Indian company received a warning letter from …
News
The Gateway to Local Adoption Series

Latest content

China approves fruquintinib combination for kidney cancer

May 29, 2026

BIOTRONIK, Charité and GHCF launch digital cardiology partnership

May 28, 2026

Endometriosis study begins recruitment in UK hospitals

May 28, 2026

MHRA authorises donidalorsen for hereditary angioedema prevention

May 27, 2026

Partnership aims to expand early access to medicines

May 26, 2026